LATEST ACTUAL 2026 EXAMINATION 1B - REVIEW OF NUCLEAR MEDICINE TECHNOLOGY (5TH ED) NORMAN E. BOLUS & KRYSTLE GLASGOW Q&A 100% PASS

LATEST ACTUAL 2025/2026 EXAMINATION 1B - REVIEW OF NUCLEAR MEDICINE TECHNOLOGY (5TH ED) NORMAN E. BOLUS & KRYSTLE GLASGOW Q&A 100% PASS 51. Based on the day's clinic schedule shown here: Patient A - Thyroid uptake and image. Patient B - Therapy for hyperthyroidism. Patient C - Cisternogram. The technologist should prepare or order which of the following Radiopharmaceutical?Need assistance on Online classes, Exams & Assignments? Reach out for instant help!! Full Course Assistance, Plagiarism-free Essay Writing, Research Paper, Dissertation, Discussion Posts, etc…. Confidential & Secure services. Tutors are available for all subjects! Email now at: A. [I-123] Sodium iodide, [I-131] Sodium iodide, and [In-111] Pentetate. B. [In-111] Oxine and [I-123] Sodium iodide. C. [I-123] Sodium iodide, [Tc-99m] Sulfur colloid, [Tc-99m] Macroaggregated albumin. D. [I-131] Sodium iodide and [In-111] Chloride. E. [I-131] Human serum albumin, [I-131] Sodium iodide, and [Tc-99m] Pertechnetate. - Answer -A. [I-123] Sodium iodide, [I-131] Sodium iodide, and [In-111] Pentetate. I-131-sodium iodide is the agent used for treatment of hyperthyroidism I-123-sodium iodide is the agent of choice for thyroid uptake and may be used for thyroid imaging as well. In-111-pentetate is administered for cisternography. 52. If an MAA kit must be reconstituted with 3.5 mL of [Tc-99m] Pertechnetate, what are the consequences if only 2.0 mL are added to the kit?A. Patients will receive more MAA particles per milliliter of [Tc-99m] MAA. B. Patients will receive more pertechnetate per milliliter of recommended patient dose.